A Prospective Digital Quality Improvement Project to Apply Best Clinical Practices to Patients At High Risk of Respiratory Complications
Latest Information Update: 29 Nov 2024
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Adverse reactions; Therapeutic Use
- 27 Nov 2024 Planned End Date changed from 1 Jul 2024 to 1 Mar 2025.
- 09 May 2024 Planned End Date changed from 1 Jan 2024 to 1 Jul 2024.
- 09 May 2024 Planned primary completion date changed from 1 Jan 2024 to 1 Jun 2024.